The Board of Directors at Syngenta Group has appointed Hengde Qin as the new Chief Financial Officer, starting from December 1, 2023. Qin will take over from Chen Lichtenstein who has served as CFO since Syngenta Group's inception but is now leaving to explore other business ventures.
Jeff Rowe will become Syngenta Group's CEO on January 1, 2024, transitioning from his current role as President of Syngenta Crop Protection. The current CEO, Erik Fyrwald, will retire at the end of the year after almost seven and a half years with the company. After retiring, Fyrwald will act as an Advisor to the Chairman of Syngenta Group and retain his position on the Board of Directors.
UK-headquartered drug development and manufacturing organization (CDMO) Quotient Sciences has appointed Thierry Van Nieuwenhove as its new CEO, effective Oct. 16, 2023. He succeeds Mark Egerton who retires after 18 years in this role.
Contract development and manufacturing organization (CDMO) AmbioPharm has appointed industry veteran Brian Gregg as CEO. Gregg, who has more than 30 years of experience in the peptide CDMO industry, succeeds Tim Nieters, who will be stepping down after seven years with the company.
Borealis has appointed two vice presidents within its polyolefins business unit, effective Sep. 1, 2023.
US contract development and manufacturing organization (CDMO) Veranova has appointed William Sanders as global vice president of chemical development operations, effective Sep. 18, 2023.
North American contract manufacturer Jubilant HollisterStier has appointed Ian Fuller as its new vice president of Operations.
Specialty chemicals and food ingredients distributor Azelis has appointed Evy Hellinckx as CEO of Azelis EMEA, effective Jan. 1, 2024. She succeeds Anna Bertona, who will take on her new role as Azelis Group CEO at the beginning of next year.
Barentz has appointed Peter Boone as its new CEO, effective Oct. 1, 2023. He succeeds Hidde van der Wal, who is to retire after leading the company more than 20 years.
Veranova announced the appointment of Victoria Brown as the company’s SVP, Chief Human Resources Officer (CHRO) based in Devens, MA, US.
Maurizio Sartorato has joined international API supplier Olon as Vice President of the group's Biotech division. In his new role, he will be a member of Olon’s leadership team.
Germany-headquartered healthcare company Fresenius Medical Care has appointed Martin Fischer as its new chief financial officer, effective Oct. 1, 2023.
Ingenza has appointed Steve Jones as chief financial officer (CFO), effective immediately.
Hanno Scheffczik has been appointed as the new Managing Director of Temmler Pharma, a member of the Aenova Group. Effective Mar. 1, 2023, he succeeds Alfred Veit, who is retiring.
Bowing to growing pressure from activist investors with different missions, the supervisory board of tradition-steeped German pharmaceuticals and agrochemicals player Bayer has announced the appointment of a new CEO to succeed embattled incumbent Werner Baumann — a year before the end of the current chief executive’s regular term.
From next year, GSK’s top management will be led by a double female team, a pioneering move for the global pharmaceutical industry. The UK drugs giant this week announced the appointment of Julie Brown, the first woman to be its chief financial officer.
German specialty chemicals producer Lanxess and private equity group Advent International have named Calum MacLean as CEO-designate of their planned joint venture for high-performance engineering plastics.
CEO Werner Baumann may be headed for an early exit from Bayer, Bloomberg reports.
Rentschler Biopharma has appointed Mark Caswell as Vice President and Site Head. He joined Rentschler in July 2022 and is managing all operations at the company’s US facilities in Milford, MA.
Martial Lecat and Philippe Combette will cease their functions within the Safic-Alcan Executive Committee on Apr. 1, 2022. At the same time, Combette, current Chairman of Safic-Alcan, will hand over the presidency of the group to Yann Lissillour. Lectat and Combette joined Safic-Alcan in June and October 1988 respectively.
US biobased chemical company DMC Biotechnologies has appointed Kelly Smith as Vice President R&D. Previously, she was head of bioprocessing and formulation development at Joyn Bio.
Dr. Reddy's has appointed Akhil Ravi as CEO for its wholly-owned subsidiary Aurigene Pharmaceutical Services effective Feb. 1, 2022.
Perstorp has appointed Ib Jensen as new CFO, effective Feb. 1, 2022. He takes over the CFO role from Ulf Berghult, who will leave Perstorp in April.
US chemicals and materials group Gelest has named Jonathan Goff as President effective immediately. He succeeds Barry Arkles, founder of Gelest, who has officially stepped down from his role as CEO on Dec. 31, 2021.
Britain’s largest drugmaker, GlaxoSmithKline (GSK) has landed a major coup, luring Pfizer’s vaccines R&D chief away, as it tries to regain its position in the top tier of the vaccine league and build up its presence in the mRNA field. On Dec. 3, Philip Dormitzer, who had served as the US pharma giant’s chief scientific officer for RNA and viral vaccines since 2015, will say goodbye to New York and, figuratively, at least, hello to London.
Philipp Morgenthaler will join sustainable biochemicals company Circa Group as Global Head of Manufacturing.
Perstorp has appointed Patrice Pinsard as EVP Strategic Markets & Innovation, effective Oct. 18, 2021.
Solvay has appointed Pascal Chalvon Demersay to chief sustainability and government affairs officer, effective July 1, 2021, integrating the new responsibilities to his current role as chief sustainability officer.
Solvay has appointed Carmelo Lo Faro, previously president of the company’s composite materials business unit, as president of the materials segment, effective immediately.
Speciality chemicals and ingredients distributor IMCD has appointed Pilar Castellanos Pineda as Managing Director of IMCD Colombia effective May 25, 2021.
Belgian spearhead cluster Catalisti has appointed Ann Verlinden as its new Managing Director. She will succeed Jan Van Havenbergh as of Apr. 5, 2021.
PolyPeptide Group has appointed Raymond De Vré as its new Chief Executive Officer (CEO). He will succeed Jane Salik who, after 15 years in this position, will concentrate on her role on the Board of Directors.
German biopharmaceutical company Adrenomed has appointed Wolfgang Baiker as Chief Executive Officer (CEO), effective Jan. 1, 2021.
WeylChem has appointed Johannes Kanellakopoulos as new Head of Marketing & Sales for its growing Custom Manufacturing business. He took over the role on Sept. 1 with the aim of fully exploiting the group's capabilities.
Ulf Berghult has been appointed as Perstorp’s new CFO as of mid-February. He joins the group from Trelleborg, where he held the position as CFO since 2012.
